ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

NZM2 Novonesis AS

55.12
-0.28 (-0.51%)
31 May 2024 - Cerrado
Datos en tiempo real
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Novonesis AS NZM2 Tradegate Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.28 -0.51% 55.12 16:50:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
55.60 54.62 55.60 55.12 55.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202404:25GLOBETrading by management and close relations of management
29/5/202409:59GLOBETrading by management and close relations of management
17/5/202405:39GLOBETrading by management and close relations of management
08/5/202408:21GLOBETrading by management and close relations of management
03/5/202400:57GLOBEQ1 update: Novonesis delivers 4% organic sales growth in..
03/5/202400:56GLOBETrading statement Q1 2024
30/4/202411:02GLOBEResolutions from the annual shareholders’ meeting 2024
08/4/202408:17GLOBEInvitation to the annual shareholders’ meeting
08/4/202404:58GLOBEShare-based legacy RSU program granted
21/3/202401:26GLOBE2024 outlook and pro forma financials
18/3/202409:26GLOBENovonesis will host a conference call regarding 2024 outlook..
04/3/202410:06GLOBEResolutions from the Extraordinary Shareholders’ Meeting..
09/2/202403:00GLOBEInvitation to an extraordinary shareholders’ meeting of..
08/2/202412:52GLOBEThe Novozymes Report 2023
02/2/202407:13GLOBETrading by management and close relations of management
02/2/202401:28GLOBESettlement of the combination of Novozymes and Chr. Hansen..
01/2/202401:00GLOBELegacy Novozymes delivers solid last full-year results
01/2/202400:59GLOBEResults update for 2023 – unaudited
31/1/202407:20GLOBETotal number of voting rights and capital on January 31,..
29/1/202408:59GLOBETrading by management and close relations of management
29/1/202406:13GLOBEMajor shareholder announcement
29/1/202404:27GLOBEThe combination of Novozymes and Chr. Hansen is now..
29/1/202404:25GLOBECompletion of the combination between Novozymes and Chr...
26/1/202405:06GLOBEAll necessary regulatory approvals have been obtained for..
20/12/202308:00GLOBESouth Korean merger approval granted
13/12/202307:46GLOBENovozymes’ updated financial calendar
12/12/202310:10GLOBEUpdate on the merger approval process for the combination of..
24/11/202303:20GLOBETrading by management and close relations of management
20/11/202301:00GLOBEUpdate on merger EC offered remedy proposal
09/11/202301:51GLOBENovozymes launches Quara® LowP for renewable diesel..
30/10/202309:11GLOBETrading by management and close relations of management
26/10/202301:01GLOBENovozymes accelerates growth in Q3 and is on track to..
26/10/202300:59GLOBEInterim report for 9M 2023
12/10/202305:02GLOBEInterim dividend payment
10/10/202300:59GLOBEExecutive Leadership Team and organizational structure..
04/9/202304:47GLOBEUpdate on the combination of Novozymes and Chr. Hansen:..